Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
Clinical trial NCT00335075 · COMPLETED
Trial details
- NCT number
- NCT00335075
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-02
- Primary completion
- 2006-02-23
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.